IRBIO has benefited from the European Social Fund for Regional Development twice, thanks to the support of the notice no. 05/2017 (around 7 million euros) and then Notice no. 2/2023 (approximately 6 million euros).

The Research Infrastructure for Integrated Biology (IRBIO) is a key resource in the Trentino area to support research, technology transfer, and training carried out by various departments and centers of the University of Trento, such as the CIBIO Department, the CISMED research center and the CIMEC research center. IRBIO comprises centralized, highly specialized, and shared technological platforms called core facilities (CF). The CFs of a biomedical research center such as CIBIO represent the fundamental infrastructure for implementing cutting-edge and internationally competitive research projects. The organization in CF was born from the growing technological complexity in the life sciences and the need to ensure researchers have access to innovative, sophisticated, and very expensive investigation methods. These investigation methods require the purchase and maintenance of cutting-edge instrumentation and the latter's management by highly qualified personnel. 

This FESR project proposes an investment aimed at updating and strengthening IRBIO instrumentation to maintain the excellence of CIBIO and, consequently, guarantee the ten-year success of the Trentino project on biotechnology for health. 

The objectives are:

1. Updating and strengthening the Core Facilities to maintain and consolidate excellent research services;
2. Strengthening an ecosystem with impact on the territory in the biomedical sector as a result of opening the infrastructure to the scientific, academic, and corporate community at a national and international level.

The implementation of this project will have a tremendous impact:

• in maintaining and increasing the high quality of CIBIO's research and the services offered by the CFs internally and externally; 
• in consolidating the local, national, and international collaborations in the academic and corporate fields in the biomedical and biotechnological sectors;
• in implementing innovative projects aimed at the implementation of precision medicine in collaboration with clinical centers; 
• in supporting entrepreneurial initiatives and consequent knowledge transfer; 
• in training new professional figures (such as Core Facilities managers) and the training of young researchers (doctoral students and post-docs) on the use of cutting-edge technologies.